Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine: COMMENT from Gruel et al.: RESPONSE from Kahn et al

被引：2

作者：

Kahn, Fredrik ^{[1
]}

Shannon, Oongh ^{[1
]}

Bjorck, Lars ^{[1
]}

机构：

[1] Lund Univ, Div Infect Med, Clin Sci, Lund, Sweden

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2021年 / 19卷 / 10期

关键词：

drug-related side effects and adverse reactions; IdeS; platelet factor 4; thrombocytopenia; vaccine; IDES;

D O I：

10.1111/jth.15467

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2633 / 2633

页数：1

共 50 条

[31] Response to: Van Wyk et al. letter to the editor regarding 'Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis'
Hulscher, Nicolas
Hodkinson, Roger
Makis, William
McCullough, Peter A.
ESC HEART FAILURE, 2024, 11 (04): : 2476 - 2478
[32] Reply to the comments on "Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?" from Wada et al.
Iba, Toshiaki
Levy, Jerrold H.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (12) : 3645 - 3646
[33] Response to Wyatt et al.'s comment on "Changes in traumatic mechanisms of injury in Southern California related to COVID-19: Penetrating trauma as a second pandemic"
Yeates, Eric O.
Nahmias, Jeffry
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2021, 91 (01): : E38 - E38
[34] Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al.
Lim, Sai Kiang
Giebel, Bernd
Weiss, Daniel J.
Witwer, Kenneth W.
Rohde, Eva
STEM CELLS AND DEVELOPMENT, 2020, 29 (14) : 877 - 878
[35] Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
Heffler, Enrico
Detoraki, Aikaterini
Contoli, Marco
Papi, Alberto
Paoletti, Giovanni
Malipiero, Giacomo
Brussino, Luisa
Crimi, Claudia
Morrone, Daniela
Padovani, Marianna
Guida, Giuseppe
Gerli, Alberto Giovanni
Centanni, Stefano
Senna, Gianenrico
Paggiaro, Pierluigi
Blasi, Francesco
Canonica, Giorgio Walter
ALLERGY, 2021, 76 (03) : 961 - 962
[36] COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan et al, 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al' by Andreica et al and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin et al
Gianfrancesco, Milena
Hyrich, Kimme L.
Yazdany, Jinoos
Machado, Pedro M.
Robinson, Philip C.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (10)
[37] Response to Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34: 2413-2417
Calleja, Ana I.
Arenillas, Juan F.
DIABETES CARE, 2012, 35 (06) : E50 - E50
[38] Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands"
Kant, Agnes
van Hunsel, Florence
DRUG SAFETY, 2022, 45 (08) : 925 - 926
[39] Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
Agnes Kant
Florence van Hunsel
Drug Safety, 2022, 45 : 925 - 926
[40] Response to: 'Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al
Duret, Pierre-Marie
Spielmann, Lionel
Messer, Laurent
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05) : E80 - +

← 1 2 3 4 5 →